ENHO and pancreatic adenocarcinoma: In light of the paradoxical effects observed for ENHO and its product Adropin across different cancer types, this study aimed to delineate the genetic and transcriptomic landscape of ENHO in PAAD patients, elucidating its prognostic significance and association with the tumor microenvironment.